Patents by Inventor Christina Gloeckel

Christina Gloeckel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9504663
    Abstract: The present invention provides a composition comprising at least one prostacyclin or prostacyclin analog or a pharmaceutically acceptable salt thereof and at least one phosphodiesterase (PDE) 4 inhibitor and optionally a further PDE inhibitor for use in preventing or treating cystic fibrosis by selectively increasing the cAMP levels in bronchoepithelial cells.
    Type: Grant
    Filed: February 3, 2012
    Date of Patent: November 29, 2016
    Assignee: SciPharm SaRL
    Inventors: Michael Freissmuth, Christina Gloeckel, Xaver Koenig, Simon Keuerleber
  • Publication number: 20160175319
    Abstract: The present invention provides compositions comprising a prostacyclin or prostacyclin analogue, or a pharmaceutically acceptable salt thereof for use in preventing or treating cystic fibrosis. The invention also provides the use of a kit comprising a prostacyclin or prostacyclin analogue for treating or preventing a condition associated with cystic fibrosis in a subject.
    Type: Application
    Filed: December 22, 2015
    Publication date: June 23, 2016
    Inventors: Michael FREISSMUTH, Xaver KOENIG, Christina GLOECKEL
  • Publication number: 20140018430
    Abstract: The present invention provides a composition comprising at least one prostacyclin or prostacyclin analogue or a pharmaceutically acceptable salt thereof and at least one phosphodiesterase (PDE) 4 inhibitor and optionally a further PDE inhibitor for use in preventing or treating cystic fibrosis by selectively increasing the cAMP levels in bronchoepithelial cells.
    Type: Application
    Filed: February 3, 2012
    Publication date: January 16, 2014
    Applicant: SciPharm SaRL
    Inventors: Michael Freissmuth, Christina Gloeckel, Xaver Koenig, Simon Keuerleber
  • Publication number: 20120184622
    Abstract: The present invention provides compositions comprising a prostacyclin or prostacyclin analogue, or a pharmaceutically acceptable salt thereof for use in preventing or treating cystic fibrosis. The invention also provides the use of a kit comprising a prostacyclin or prostacyclin analogue for treating or preventing a condition associated with cystic fibrosis in a subject.
    Type: Application
    Filed: August 5, 2010
    Publication date: July 19, 2012
    Applicant: SCIPHARM SaRL
    Inventors: Michael Freissmuth, Xaver Koenig, Christina Gloeckel